Close
GMP
FDA Academy
Downloadables
Bids and Awards
Careers
FAQs
Report
Contact Us
Menu
GMP
FDA Academy
Downloadables
Bids and Awards
Careers
FAQs
Report
Contact Us
Search
Home
About FDA
Transparency
Issuances
Advisories
Administrative Order
Executive Order
FDA Circular
FDA Memorandum
Memorandum Circular
Republic Act
Old Issuances
Old FDA Advisories
Services
eServices
ePortal
ePortal2
Doctrack
RRDportal
Menu
Home
About FDA
Transparency
Issuances
Advisories
Administrative Order
Executive Order
FDA Circular
FDA Memorandum
Memorandum Circular
Republic Act
Old Issuances
Old FDA Advisories
Services
eServices
ePortal
ePortal2
Doctrack
RRDportal
Newsletters and Bulletins
Pharmacovigilance
Information for the patients
Information for doctors, nurses, and pharmacists
Information for pharmaceutical industry
COVID-19 vaccines information
Newsletters and bulletins
Forms
Glossary
FAQs
Safety Information
2019
Incorrect Use of Anti-Fungal Corticosteroid Combination Therapy
Unsafe use of glutathione as skin lightening agent
SGLT2 inhibitors and risk of necrotizing fasciitis of the perineum (Fournier’s gangrene)
Fluoroquinolones and risk of aortic aneurysm and dissection
Last updated: 12 August 2022
Shares
